Osteoporosis and Osteopenia Among Patients with Type 2 Diabetes Aged More Than 50 years and Role of Hypoglycemic Drug Therapy

Volume 20 No 9 (2022)

Nema Abd El-Wanees Abd El-Shafy , Hamed Abd El-Aziz Deraz , Atef Goda Hussin , Mostafa Mohamed Assy

DOI: 10.14704/nq.2022.20.9.NQ44254

Abstract

Both type 2 diabetes mellitus (T2DM) and osteoporosis affect a large proportion of older people around the world and are major public health threats. Though the relationship between T2DM and osteoporosis has been widely investigated, it remains controversial. However, the association between clinical characteristics (especially hypoglycemic drug use) and osteoporosis/osteopenia remains unclear. Aim: To decrease morbidities resulting from osteoporosis and osteopenia as a complication of type 2 diabetes among patients aged > 50 years. S

Keywords

Osteoporosis, Osteopenia, Diabetes, Hypoglycemic

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.